{"id":1822,"date":"2017-12-06T01:07:02","date_gmt":"2017-12-06T00:07:02","guid":{"rendered":"http:\/\/tecnodiabetes.ai2.upv.es\/?p=1822"},"modified":"2023-02-15T17:45:45","modified_gmt":"2023-02-15T16:45:45","slug":"breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial","status":"publish","type":"post","link":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/","title":{"rendered":"Breves &#8211; Lilly inicia su primer estudio de p\u00e1ncreas artificial"},"content":{"rendered":"<p>Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de <strong>p\u00e1ncreas artificial<\/strong>, que denomina AID &#8211; Automated Insulin Delivery &#8211; y es uno de los componentes de su <strong>Connected Diabetes Ecosystem<\/strong>. Ayer se anunciaba el inicio de su primer estudio para evaluar la funcionalidad y seguridad del sistema. \u00c9ste integra una bomba licenciada a DEKA, el monitor continuo de glucosa en colaboraci\u00f3n con Dexcom, y el algoritmo de control adquirido a Class AP, start-up surgida de la investigaci\u00f3n del grupo del Dr. Haidar en Montreal centrado en el control bihormonal y su comparativa con los sistemas unihormonales. <\/p>\n<p>Fuentes:<br \/>\n<a href=\"https:\/\/investor.lilly.com\/releasedetail.cfm?ReleaseID=1050744\" target=\"_blank\" rel=\"noopener\">https:\/\/investor.lilly.com\/releasedetail.cfm?ReleaseID=1050744<\/a><br \/>\n<a href=\"https:\/\/www.healthline.com\/diabetesmine\/news-lilly-developing-insulin-pump-smart-pen-device#2\" target=\"_blank\" rel=\"noopener\">https:\/\/www.healthline.com\/diabetesmine\/news-lilly-developing-insulin-pump-smart-pen-device#2<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, que denomina AID &#8211; Automated Insulin Delivery &#8211; y es uno de los componentes de su Connected Diabetes Ecosystem. Ayer se anunciaba el inicio de su primer estudio para evaluar la funcionalidad y seguridad del sistema. \u00c9ste integra una bomba licenciada [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1821,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[45,53],"tags":[],"class_list":["post-1822","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacion","category-tecnologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes<\/title>\n<meta name=\"description\" content=\"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes\" \/>\n<meta property=\"og:description\" content=\"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/\" \/>\n<meta property=\"og:site_name\" content=\"Tecnodiabetes\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Tecnodiabetes-1788690764738148\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-06T00:07:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-15T16:45:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"219\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tecnodiabetes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@tecnodiabetes\" \/>\n<meta name=\"twitter:site\" content=\"@tecnodiabetes\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tecnodiabetes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/\"},\"author\":{\"name\":\"Tecnodiabetes\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#\\\/schema\\\/person\\\/ce639af4200774ceb5cf516565eedbda\"},\"headline\":\"Breves &#8211; Lilly inicia su primer estudio de p\u00e1ncreas artificial\",\"datePublished\":\"2017-12-06T00:07:02+00:00\",\"dateModified\":\"2023-02-15T16:45:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/\"},\"wordCount\":129,\"image\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/Lilly_Logo.jpeg\",\"articleSection\":[\"Innovaci\u00f3n\",\"Tecnolog\u00eda\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/\",\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/\",\"name\":\"Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/Lilly_Logo.jpeg\",\"datePublished\":\"2017-12-06T00:07:02+00:00\",\"dateModified\":\"2023-02-15T16:45:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#\\\/schema\\\/person\\\/ce639af4200774ceb5cf516565eedbda\"},\"description\":\"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/Lilly_Logo.jpeg\",\"contentUrl\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/Lilly_Logo.jpeg\",\"width\":400,\"height\":219,\"caption\":\"Eli Lilly and Company logo. (PRNewsFoto)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breves &#8211; Lilly inicia su primer estudio de p\u00e1ncreas artificial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#website\",\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/\",\"name\":\"Tecnodiabetes\",\"description\":\"Divulgaci\u00f3n Cient\u00edfica sobre Diabetes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/#\\\/schema\\\/person\\\/ce639af4200774ceb5cf516565eedbda\",\"name\":\"Tecnodiabetes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g\",\"caption\":\"Tecnodiabetes\"},\"url\":\"https:\\\/\\\/tecnodiabetes.ai2.upv.es\\\/index.php\\\/author\\\/paneldecontrol\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes","description":"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/","og_locale":"es_ES","og_type":"article","og_title":"Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes","og_description":"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem","og_url":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/","og_site_name":"Tecnodiabetes","article_publisher":"https:\/\/www.facebook.com\/Tecnodiabetes-1788690764738148\/","article_published_time":"2017-12-06T00:07:02+00:00","article_modified_time":"2023-02-15T16:45:45+00:00","og_image":[{"width":400,"height":219,"url":"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg","type":"image\/jpeg"}],"author":"Tecnodiabetes","twitter_card":"summary_large_image","twitter_creator":"@tecnodiabetes","twitter_site":"@tecnodiabetes","twitter_misc":{"Escrito por":"Tecnodiabetes","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#article","isPartOf":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/"},"author":{"name":"Tecnodiabetes","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#\/schema\/person\/ce639af4200774ceb5cf516565eedbda"},"headline":"Breves &#8211; Lilly inicia su primer estudio de p\u00e1ncreas artificial","datePublished":"2017-12-06T00:07:02+00:00","dateModified":"2023-02-15T16:45:45+00:00","mainEntityOfPage":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/"},"wordCount":129,"image":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#primaryimage"},"thumbnailUrl":"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg","articleSection":["Innovaci\u00f3n","Tecnolog\u00eda"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/","url":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/","name":"Breves - Lilly inicia su primer estudio de p\u00e1ncreas artificial - Tecnodiabetes","isPartOf":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#primaryimage"},"image":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#primaryimage"},"thumbnailUrl":"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg","datePublished":"2017-12-06T00:07:02+00:00","dateModified":"2023-02-15T16:45:45+00:00","author":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#\/schema\/person\/ce639af4200774ceb5cf516565eedbda"},"description":"Lilly se une a las compa\u00f1\u00edas que est\u00e1n desarrollando su sistema de p\u00e1ncreas artificial, uno de los componentes de su Connected Diabetes Ecosystem","breadcrumb":{"@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#primaryimage","url":"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg","contentUrl":"https:\/\/tecnodiabetes.ai2.upv.es\/wp-content\/uploads\/2017\/12\/Lilly_Logo.jpeg","width":400,"height":219,"caption":"Eli Lilly and Company logo. (PRNewsFoto)"},{"@type":"BreadcrumbList","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/breves-lilly-inicia-su-primer-estudio-de-pancreas-artificial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/tecnodiabetes.ai2.upv.es\/"},{"@type":"ListItem","position":2,"name":"Breves &#8211; Lilly inicia su primer estudio de p\u00e1ncreas artificial"}]},{"@type":"WebSite","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#website","url":"https:\/\/tecnodiabetes.ai2.upv.es\/","name":"Tecnodiabetes","description":"Divulgaci\u00f3n Cient\u00edfica sobre Diabetes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tecnodiabetes.ai2.upv.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/tecnodiabetes.ai2.upv.es\/#\/schema\/person\/ce639af4200774ceb5cf516565eedbda","name":"Tecnodiabetes","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/972115cf8623dec41d6d382df64383e0e4870477d2dd4b591064d35858849d73?s=96&d=mm&r=g","caption":"Tecnodiabetes"},"url":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/author\/paneldecontrol\/"}]}},"_links":{"self":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/posts\/1822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/comments?post=1822"}],"version-history":[{"count":5,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/posts\/1822\/revisions"}],"predecessor-version":[{"id":2966,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/posts\/1822\/revisions\/2966"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/media\/1821"}],"wp:attachment":[{"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/media?parent=1822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/categories?post=1822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tecnodiabetes.ai2.upv.es\/index.php\/wp-json\/wp\/v2\/tags?post=1822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}